This therapeutic impact across MDs on both muscle and non-muscle abnormalities is exceptional, but these wide-ranging therapeutic effects simply reflect the involvement of P2X7 activation in various disease processes. The gene discussed is P2RX7; the disease is myelodysplastic syndrome.